(Q42545511)

2 November 2017

Development of high affinity selective VIP1 receptor agonists (English)

1 reference

2 November 2017

Gourlet P

1

1 reference

2 November 2017

Vandermeers A

2

1 reference

2 November 2017

Vertongen P

3

1 reference

2 November 2017

Rathe J

4

1 reference

2 November 2017

De Neef P

5

1 reference

2 November 2017

Cnudde J

6

1 reference

2 November 2017

Waelbroeck M

7

1 reference

2 November 2017

Robberecht P

8

1 reference

2 November 2017

1 January 1997

1 reference

2 November 2017

1 reference

2 November 2017

18

1 reference

2 November 2017

1539-1545

1 reference

2 November 2017

10

1 reference

Synthesis and some pharmacological properties of the 23-peptide 15-lysine-secretin-(5-27). Special role of the residue in position 15 in biological activity of the vasoactive intestinal polypeptide

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Properties of the VIP-PACAP type II receptor stably expressed in CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Differential effects of N-terminal modifications on the biological potencies of growth hormone releasing factor analogues with varying chain lengths.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Potent stimulation of the avian exocrine pancreas by porcine and chicken vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Vasoactive Intestinal Polypeptide: Measurement, Distribution and Putative Neurotransmitter Function

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Amino acid sequence of VIP, PHI and secretin from the rabbit small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

PACAP acts through VIP type 2 receptors in the rat testis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Characterization of the VIP receptor from SUP T1 lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

A highly sensitive adenylate cyclase assay

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Gastric inhibitory polypeptide receptor, a member of the secretin- vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes are differently expressed in rat transplanted pituitary tumours (SMtTW) and in the normal gland

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900228-3

7 January 2021

10.1016/S0196-9781(97)00228-3

Identifiers

DOI

1 reference

2 November 2017

1 reference